Tag Archives: active surveillance

5-ARI delays prostate cancer progression in men with low-risk disease – ModernMedicine

The 5-alpha-reductase inhibitor dutasteride Avodart appears to delay disease progression and the initiation of active treatment in men with low-risk, localized prostate cancer, results of a 3-year international clinical trial indicate.Treatment with dutasteride also reduces cancer-related anxiety, study authors found.”The … Continue reading

Posted in Prostate Cancer | Tagged , , , | Leave a comment

Dutasteride Slows Prostate Cancer Progression – Renal and Urology News

ORLANDO—Dutasteride, a drug widely prescribed for treating benign prostatic enlargement, lowers the risk of prostate cancer PCa progression in men undergoing active surveillance for the disease, researchers concluded. via Dutasteride Slows Prostate Cancer Progression – Renal and Urology News. Dutasteride … Continue reading

Posted in Prostate Cancer | Tagged , , | Leave a comment

MedWire News – Oncology – PCA3 predicts prostate tumor volume and could indicate AS suitability

MedWire News: Prostate cancer patients urinary prostate cancer antigen 3 PCA3 scores are strongly indicative of tumor volume, and could be a useful marker of suitability for treatment with active surveillance AS, study findings show. via MedWire News – Oncology … Continue reading

Posted in Prostate Cancer | Tagged , | Leave a comment

Robotic prostatectomy findings in patients with a single microfocus (5% or Less) of Gleason 6 Prostate Cancer at Biopsy

A Single Microfocus (5% or Less) of Gleason 6 Prostate Cancer at Biopsy-Can We Predict Adverse Pathological Outcomes? Source: Urotoday While a microfocus of Gleason score 6 prostate cancer on biopsy is commonly considered low risk disease, there was a … Continue reading

Posted in Prostate Cancer | Tagged , , , | Leave a comment

Determinants of Long-Term Retention of Prostate Cancer Patients in Active Surveillance Management Programs

From Urotoday and the AUA Of the 2134 PCa cases, 169 (7.9%) had AS as their initial management. Of the 169 AS cases, 89 (53%) remained untreated throughout follow-up (mean 7.1 years) and the remaining 47% received treatment an average … Continue reading

Posted in For patients, Prostate Cancer | Tagged , , , , , | Leave a comment

Active Surveillance for Prostate Cancer Patients

From Medscape May 12, 2008 — The urine test for the PCA3 gene, already marketed for use in diagnosing prostate cancer, could also be useful in prognostication. It might have clinical application in selecting men with low-grade and low-volume tumors … Continue reading

Posted in For patients, Prostate Cancer | Tagged , , , , | Leave a comment